Hepatocellular Carcinoma with Portal Vein Thrombosis in an Eight Year Old Boy
Hina Ismail1, Raja Taha Yaseen Khan1*, Ghous Bux Soomro3, Nasir Mehmood1, Muhammad Ali Khalid1, Ghazi Abrar1, Nadir Ali1, Reeaa Harjani1, Abdul Wahid1, Danish Kumar1, Husnain Ali1, Nasir Hassan Luck1, Syed Haider Mehdi2 and Abdaal Waseem Khan2
1Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan
2Department of Surgery, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan
3Senior Author, Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan
*Corresponding Author: Raja Taha Yaseen Khan, Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan.
Received:
September 15, 2022; Published:
November 08, 2022
Abstract
Hepatocellular carcinoma with portal vein thrombosis is rarely seen in young patients. Hepatitis B can lead to HCC with PVT in the absence of cirrhosis. However, it is uncommon in age less than 40 years. Here we present to you a case of an eight year old boy with a family history of hepatitis B who developed HCC with PVT.
Keywords: Hepatitis B; Hepatocellular Carcinoma; Portal Vein Thrombosis
References
- Shirabe K., et al. “Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses”. Hepatology 14 (1991): 802-805.
- DeLeve LD., et al. “Vascular disorders of the liver”. Hepatology 49 (2009): 1729-1764.
- Korn Lertpipopmetha, Chirayu U Auewarakul. “High Incidence of Hepatitis B Infection-Associated Cirrhosis and Hepatocellular Carcinoma in the Southeast Asian Patients with Portal Vein Thrombosis”. BMC Gastroenterology 11 (2011): 66.
- Yamanaka N and Okamoto E. “Conditions favoring long-term survival after hepatectomy for hepatocellular carcinomas”. Cancer Chemotherapy and Pharmacology 23 (1989): S83-S86.
- Forner A., et al. “Hepatocellular carcinoma”. Lancet 379 (2012): 1245-1255
- Fattovich G. “Natural history and prognosis of hepatitis B”. Seminars in Liver Disease 23 (2003): 47-58.
- Bruix J and Sherman M. “Management of hepatocellular car-cinoma: an update”. Hepatology 53 (2011): 1020-1022.
- Jordi Bruix and Morris Sherman. “Management of Hepatocellular Carcinoma”. Hepatology 5 (2005): 1208-1236.
- Fattovich G. “Natural history of hepatitis B”. Journal of Hepatology 39 (2003): S50-58.
- Hsu YS., et al. “Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B”. Hepatology 35 (2002): 1522-1527.
- Huo TI., et al. “Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis”. Hepatology 28 (1998): 231-236.
- Evans AA., et al. “Eight year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences”. Cancer Epidemiology, Biomarkers and Prevention 11 (2002): 369-376.
- Siddique O., et al. “The importance of a multidisciplinary approach to hepatocellular carcinoma”. Journal of Multidisciplinary Healthcare 10 (2017): 95-100.
- Llovet JM and Bruix J. “Novel advancements in the management of hepatocellular carcinoma in 2008”. Journal of Hepatology 48 (2008): S20-37.
- Beasley RP. “Hepatitis B virus as the etiologic agent in hepatocellular carcinoma”. Hepatology 2 (1982): S21-26.
- Khalid S., et al. “Frequency of Hereditary Thrombophilia: an AKUH experience”. JPMA 54 (2004): 427.
- Ahmed I. “Prevalence of Hepatitis B and C Viral Infection Among Pregnant Women in Peshawar, Pakistan”. Hepatitis Monthly6 (2016): e36383.
- Sogaard KK., et al. “Portal vein thrombosis; risk factors, clinical presentation and treatment”. BMC Gastroenterology 7 (2007): 34.
- Amitrano L., et al. “Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis”. Journal of Hepatology 40 (2004): 736-741.
- Lin CL and Kao JH. “Risk stratification for hepatitis B virus related hepatocellular carcinoma”. Journal of Gastroenterology and Hepatology 28 (2013): 10-17.
- El-Serag HB and Rudolph KL. “Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis”. Gastroenterology 132 (2007): 2557-2576.
- Wan DW., et al. “Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States”. American Journal of Gastroenterology 106 (2011): 1994-2000.
- Reig M., et al. “BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update”. Journal of Hepatology3 (2022): 681-693.
Citation
Copyright